ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

Committee To Set Research Agenda On Breast Cancer. Justice Department Appeals Injunction On Stem Cell Research

September 3, 2010

In Brief: Preyer, Waxman Battle Over Chairmanship Of Health Group; Amos To Head Mas. ACS

January 12, 1979

Surgical Oncologists Certification Asked By SSO Workshop

December 9, 1983

Aetna No Longer To Cover HDC/BMT For Breast Cancer Outside Of Clinical Trials.

February 25, 2000

In Brief: Armitage Appointed to NCAB; UT Board Approves New Clinical Building for MDACC

May 19, 2000

In Brief: Cancer Act, Accelerated Progress, ACS President Says; Scanners Scapegoats, EMI Chief Claimes

April 7, 1978